(Q46915002)

26 December 2017

title

Renal calcium handling after rapamycin conversion in chronic allograft dysfunction (English)

1 reference

26 December 2017

1 reference

Mai-Szu Wu

1

1 reference

26 December 2017

Cheng-Chieh Hung

series ordinal

2

1 reference

26 December 2017

Chiz-Tzung Chang

series ordinal

3

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

published in

Transplant International

1 reference

26 December 2017

volume

19

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

140-145

1 reference

26 December 2017

Bone mineral density changes within six months of renal transplantation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Clinical application of sirolimus in renal transplantation: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Rapamycin in patients with chronic renal allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Role of the calcium-sensing receptor in parathyroid gland physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Calcium receptor-mediated intracellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2005.00251.X

10.1111/J.1432-2277.2005.00251.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16441363

1 reference

26 December 2017